Discontinued — last reported Q4 '19
An increase may indicate higher centralized investment in corporate infrastructure or R&D, while a decrease often reflects the successful allocation of assets to revenue-generating business segments.
This metric represents the total value of assets held at the corporate level that are not specifically allocated to indi...
Most large-cap medical device firms report similar unallocated corporate assets, though the scale varies based on the degree of centralization in their operating model.
bsx_segment_corporate_non_assets